Award Data

Vibrant Corporation and Sandia National Laboratories (SNL) propose to apply Process Compensated Resonance Testing (PCRT) to the DLA's need for an NDI method to detect counterfeit, nonconforming and improperly processed materiel. PCRT collects and analyzes the resonance frequencies of a component to detect structural defects, characterize material, analyze population variation, monitor manufacturin ...

There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a highly accurate genotype analysis technique and the computational pipeline for assessing genetic provenance in crop plants. The commercial potential of the proposed products and services is based on the need to increase crop yield and accelerate breeding programs. The prop ...

The broader impact / commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable electrification of remote oil & gas processes to reduce methane emissions, improve on-site safety, and provide leak-detection and monitoring capabilities. This will be achieved by developing a robust, efficient, small-scale power generator capable of converting on-site fuel to e ...

This Small Business Technology Transfer Phase I project will advance the development of new portable gas analysis systems. Portable analysis systems can provide timely information about the surroundings, leading to better decisions in critical situations. For law enforcement, a portable detector based on the proposed technology will enable officers to focus an investigation on specific targets, wh ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is the reduction of significant disease flare-ups in patients with Chronic Obstructive Pulmonary Disease (COPD), increase in patient quality-of-life, and a reduction of expensive and unnecessary healthcare utilization. Current at-home care support for COPD patients is often completely missing or consi ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to reduce preventable patient readmissions, streamline triage, and detect multi-organ diseases early. Currently, failures of care delivery and care coordination, overtreatment, and administrative complexity cost the American healthcare system an estimated 300 billion dollars per year, and a ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) project will be the development of a platform technology for high-throughput protein expression. The current standard for expressing panels of proteins involves extensive bioinformatics, cloning, in vivo expression, and assays. This method takes significant expertise in disparate fields, and weeks to months o ...

This SBIR Phase I project will develop a revolutionary new tool for creating engaging language-learning content. Educational publishers, teachers, and even students will be able to create artificially intelligent "virtual role-players" that converse in foreign languages, responding to either speech or text input. Large-scale on-line communities of educators will be able to create, customize, and s ...